AMERIPRISE FINANCIAL INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,722,249
-61.4%
630,150
-41.0%
0.00%
-50.0%
Q2 2023$7,044,418
+4.7%
1,068,956
+7.9%
0.00%0.0%
Q1 2023$6,729,197
+8.2%
991,045
+17.7%
0.00%0.0%
Q4 2022$6,221,000
-31.0%
842,151
-7.7%
0.00%
-33.3%
Q3 2022$9,015,000
+5.7%
912,323
+16.6%
0.00%0.0%
Q2 2022$8,527,000
-5.6%
782,425
-2.0%
0.00%0.0%
Q1 2022$9,033,000
-24.2%
798,754
+5.2%
0.00%0.0%
Q4 2021$11,915,000
+84.6%
759,281
+101.6%
0.00%
+50.0%
Q3 2021$6,454,000
-18.5%
376,613
+2.3%
0.00%0.0%
Q2 2021$7,919,000
+56.8%
368,197
+9.5%
0.00%0.0%
Q1 2021$5,051,000
-2.3%
336,307
-14.5%
0.00%0.0%
Q4 2020$5,168,000
+16.3%
393,306
-14.5%
0.00%0.0%
Q3 2020$4,444,000
+5.7%
459,988
+25.2%
0.00%0.0%
Q2 2020$4,204,000
+9.1%
367,418
-1.3%
0.00%0.0%
Q1 2020$3,855,000
-33.8%
372,102
+4.8%
0.00%0.0%
Q4 2019$5,826,000
+21.9%
355,032
-1.3%
0.00%0.0%
Q3 2019$4,779,000
-11.6%
359,836
-6.2%
0.00%0.0%
Q2 2019$5,404,000
-35.3%
383,491
-15.5%
0.00%
-50.0%
Q1 2019$8,347,000
-49.1%
453,568
-27.7%
0.00%
-50.0%
Q4 2018$16,398,000
+254.5%
627,599
+211.4%
0.01%
+300.0%
Q3 2018$4,626,000
+125.4%
201,561
+87.1%
0.00%
+100.0%
Q2 2018$2,052,000
+23.8%
107,726
+9.5%
0.00%0.0%
Q1 2018$1,657,000
+24.3%
98,385
+12.3%
0.00%0.0%
Q4 2017$1,333,000
-15.5%
87,646
-0.6%
0.00%0.0%
Q3 2017$1,578,000
+9.5%
88,160
-0.3%
0.00%0.0%
Q2 2017$1,441,000
-25.0%
88,436
-34.1%
0.00%0.0%
Q4 2014$1,922,000
+205.1%
134,194
+121.3%
0.00%
Q3 2014$630,000
+10400.0%
60,645
+17227.1%
0.00%
Q2 2014$6,000
-92.8%
350
-93.2%
0.00%
Q1 2014$83,000
-82.5%
5,130
-86.6%
0.00%
Q4 2013$474,000
-51.3%
38,230
-56.9%
0.00%
-100.0%
Q3 2013$974,000
+5629.4%
88,745
+3939.4%
0.00%
Q2 2013$17,0002,1970.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders